Stocks With Rising Relative Strength: BioNTech ADR
Investor's Business Daily - 22 Apr 2025Stocks With Rising Relative Strength: BioNTech ADR ...
biontech
Stocks With Rising Relative Strength: BioNTech ADR ...
BioNTech Earnings: COVID Vaccine Giant Sets Critical Q1 2025 Financial Results Date
Stock Titan - 22 Apr 2025BioNTech Earnings: COVID Vaccine Giant Sets Critical Q1 2025 Financial Results Date ...
BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025
TradingView - 22 Apr 2025BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025 ...
Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
PharmaTimes - 22 Apr 2025Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine ...
BioNTech shows off lung cancer survival data behind phase 3 push for red-hot bispecific
Fierce Biotech - 28 Mar 2025BioNTech shows off lung cancer survival data behind phase 3 push for red-hot bispecific ...
BioNTech’s Bispecific Elicits Treatment Response in Majority of SCLC Patients
BioSpace - 28 Mar 2025BioNTech’s Bispecific Elicits Treatment Response in Majority of SCLC Patients ...
BioNTech SE (BNTX) Q4 2024 Earnings Call Highlights: Navigating Challenges and Advancing Innovations
Yahoo - 21 Apr 2025BioNTech SE (BNTX) Q4 2024 Earnings Call Highlights: Navigating Challenges and Advancing Innovations ...
BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025 | BNTX Stock News
GuruFocus - 22 Apr 2025BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025 | BNTX Stock News ...
BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025
Bluefield Daily Telegraph - 22 Apr 2025BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025 ...
FDA puts clinical hold on BioNTech’s malaria vaccine trial
Clinical Trials Arena - 05 Mar 2025FDA puts clinical hold on BioNTech’s malaria vaccine trial ...
BioNTech guides for worse-than-expected 2025 revenue decline
Reuters - 10 Mar 2025BioNTech guides for worse-than-expected 2025 revenue decline ...
BioNTech's PD-L1/VEGF-A impresses in SCLC as bispecific battle heats up
FirstWord Pharma - 28 Mar 2025BioNTech's PD-L1/VEGF-A impresses in SCLC as bispecific battle heats up ...
Fierce Pharma Asia—Pharma CEOs meet Xi Jinping; Trump's tariffs; BioNTech's bispecific data
Fierce Pharma - 04 Apr 2025Fierce Pharma Asia—Pharma CEOs meet Xi Jinping; Trump's tariffs; BioNTech's bispecific data ...
Gaithersburg-Based Novavax’s COVID-19 Vaccine Shows Lower Side Effects Than Pfizer-BioNTech
The MoCo Show - - 17 Apr 2025Gaithersburg-Based Novavax’s COVID-19 Vaccine Shows Lower Side Effects Than Pfizer-BioNTech ...
Duality Biologics and BioNTech Presented Positive Interim Data for Investigational B7-H3 Antibody-Drug Conjugate BNT324/DB-1311 in Advanced Solid Tumors at the ESMO Asia Congress 2024
PR Newswire - 05 Dec 2024Duality Biologics and BioNTech Presented Positive Interim Data for Investigational B7-H3 Antibody-Drug Conjugate BNT324/DB-1311 in Advanced Solid Tumors at the ESMO Asia Congress 2024 ...
BioNTech passes on Autolus' CD19/CD22 CAR-T amid pipeline prioritization
Fierce Biotech - 20 Mar 2025BioNTech passes on Autolus' CD19/CD22 CAR-T amid pipeline prioritization ...
FDA Pauses Study of BioNTech’s Malaria Shot as Problems for Vaccine Space Mount
BioSpace - 05 Mar 2025FDA Pauses Study of BioNTech’s Malaria Shot as Problems for Vaccine Space Mount ...
Health Rounds: Roche/BioNTech experimental vaccine shows early promise in pancreatic cancer
Reuters - 05 Mar 2025Health Rounds: Roche/BioNTech experimental vaccine shows early promise in pancreatic cancer ...
BioNTech inks settlements with NIH, Penn in COVID-19 vaccine royalty disputes
Fierce Pharma - 03 Jan 2025BioNTech inks settlements with NIH, Penn in COVID-19 vaccine royalty disputes ...